ArticleNeural regeneration research2021

Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation.

Neda Anastassova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.